0.011EUR
1.87 MEUR
50.93 MEUR
76.79 M
About LAVIPHARM S.A. (CR)
Sector
Headquarters
Paiania
Employees (FY)
307
Website
Founded
1911
ISIN
GRS246003008
FIGI
BBG000FRM981
Lavipharm SA engages in the manufacture and import of pharmaceuticals and veterinary products. It offers products such as pharmaceuticals, over the counter medicines, and dermacosmetics. The company was founded in 1911 and is headquartered in Paiania, Greece.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of LAVI is 0.78 EUR — it has decreased by 4.51% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ATHEX exchange LAVIPHARM S.A. (CR) stocks are traded under the ticker LAVI.
Yes, you can track LAVIPHARM S.A. (CR) financials in yearly and quarterly reports right on TradingView.
Like other stocks, LAVI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LAVIPHARM S.A. (CR) stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 307.00 employees. See our rating of the largest employees — is LAVIPHARM S.A. (CR) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LAVIPHARM S.A. (CR) EBITDA is 8.35 M EUR, and current EBITDA margin is 16.39%. See more stats in LAVIPHARM S.A. (CR) financial statements.